Evidence for nonspecific adsorption of targeted retrovirus vector particles to cells

Gene Therapy

Volumn 8, Issue 14, 2001, Pages 1088-1096

  Pizzato, M ^a,b   Blair, E D ^b   Fling, M ^c   Kopf, J ^c   Tomassetti, A ^d   Weiss, R A ^a   Takeuchi, Y ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

^c GLAXOSMITHKLINE   (United States)

^d NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

FR; MLV; MOv18; Targeting

Indexed keywords

ANTIBODY; CELL RECEPTOR; FOLIC ACID; LIGAND; LIPID; VIRUS GLYCOPROTEIN; VIRUS VECTOR;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CANCER CELL; CELL TYPE; CHIMERA; CONTROLLED STUDY; FLUORESCENCE ACTIVATED CELL SORTER; GENE OVEREXPRESSION; GENE THERAPY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IN VIVO STUDY; MOUSE; MURINE LEUKEMIA VIRUS; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN MODIFICATION; RETROVIRUS; TARGET CELL; VIRUS ADSORPTION; VIRUS CELL INTERACTION; VIRUS ENVELOPE; VIRUS INFECTION; VIRUS PARTICLE;

3T3 CELLS; ADSORPTION; ANIMALS; ANTIBODIES, MONOCLONAL; BLOTTING, WESTERN; CARRIER PROTEINS; FEMALE; FLOW CYTOMETRY; GENE TARGETING; GENE THERAPY; GENES, IMMUNOGLOBULIN; GENETIC ENGINEERING; GENETIC VECTORS; IMMUNOGLOBULIN FRAGMENTS; IMMUNOGLOBULIN VARIABLE REGION; LEUKEMIA VIRUS, MURINE; MICE; OVARIAN NEOPLASMS; RECEPTORS, CELL SURFACE;

EID: 0034796426     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301494     Document Type: Article

References (35)

1. Modifying the host range properties of retroviral vectors
2. Retroviral vectors displaying functional antibody fragments
3. Tissue-specific targeting of retroviral vectors through ligand-receptor interactions
4. Generation of targeted retroviral vectors by using single-chain variable fragment: An approach to in vivo gene delivery
5. Ligand-directed retroviral targeting of human breast cancer cells
6. Targeted infection of a retrovirus bearing a CD4-Env chimera into human cells expressing human immunodeficiency virus type 1
7. Retroviral retargeting by envelopes expressing an N-terminal binding domain
8. Targeted infection of human cells via major histocompatibility complex class I molecules by Moloney murine leukemia virus-derived viruses displaying single-chain antibody fragment-envelope fusion proteins
9. Targeting strategy for gene delivery to carcino-embryonic antigen- producing cancer cells by retrovirus displaying a single-chain variable fragment antibody
10. Retroviral vector targeting to melanoma cells by single-chain antibody incorporation in envelope
11. Retroviral vector targeting human cells via c-Kit-stem cell factor interaction
12. Expression of chimeric envelope proteins in helper cell lines and integration into Moloney murine leukemia virus particles
13. Targeting retroviral vectors to CD34-expressing cells: Binding to CD34 does not catalyze virus-cell fusion
14. Modification of retroviral tropism by display of IGF-I
15. Characterization of human ovarian carcinoma-associated antigens defined by novel monoclonal antibodies with tumor-restricted specificity
16. Folate-binding protein is a marker for ovarian cancer
17. Cloning of a tumor-associated antigen: MOv18 and MOv19 antibodies recognize a folate-binding protein
18. Targeted drug delivery via the folate receptor
19. Targeted gene delivery by tropism-modified adenoviral vectors
20. Regression of advanced ovarian carcinoma by intraperitoneal treatment with autologous T lymphocytes retargeted by a bispecific monoclonal antibody
21. High-titer packaging cells producing recombinant retroviruses resistant to human serum
22. Downmodulation of caveolin-1 expression in human ovarian carcinoma is directly related to alpha-folate receptor overexpression
23. Initial binding of murine leukemia virus particles to cells does not require specific env-receptor interaction
24. Improvement of retroviral retargeting by using amino acid spacers between an additional binding domain and the N terminus of Moloney murine leukemia virus SU
25. A proline-rich motif downstream of the receptor binding domain modulates conformation and fusogenicity of murine retroviral envelopes
26. Masking of retroviral envelope functions by oligomerizing polypeptide adaptors
27. Retroviral display of antibody fragments; interdomain spacing strongly influences vector infectivity
28. Targeting of retroviral vectors through protease-substrate interactions
29. Envelope-binding domain in the cationic amino acid transporter determines the host range of ecotropic murine retroviruses
30. Heparin binds to murine leukemia virus and inhibits Env-independent attachment and infection
31. Endocytosis of GPI-linked membrane folate receptor-alpha
32. Gene transfection and expression of the ovarian carcinoma marker folate binding protein on NIH/3T3 cells increases cell growth in vitro and in vivo
33. Type C retrovirus inactivation by human complement is determined by both the viral genome and the producer cell
34. A neutralizable epitope common to the envelope glycoproteins of ecotropic, polytropic, xenotropic, and amphotropic murine leukemia viruses